0001013606-19-000022.txt : 20190102
0001013606-19-000022.hdr.sgml : 20190102
20190102210328
ACCESSION NUMBER: 0001013606-19-000022
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181230
FILED AS OF DATE: 20190102
DATE AS OF CHANGE: 20190102
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Thompson Matthew
CENTRAL INDEX KEY: 0001740988
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-28440
FILM NUMBER: 19503460
MAIL ADDRESS:
STREET 1: 2 MUSICK
CITY: IRVINE
STATE: CA
ZIP: 92618
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ENDOLOGIX INC /DE/
CENTRAL INDEX KEY: 0001013606
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 680328265
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2 MUSICK
CITY: IRVINE
STATE: CA
ZIP: 92618
BUSINESS PHONE: 9495984741
MAIL ADDRESS:
STREET 1: 2 MUSICK
CITY: IRVINE
STATE: CA
ZIP: 92618
FORMER COMPANY:
FORMER CONFORMED NAME: RADIANCE MEDICAL SYSTEMS INC /DE/
DATE OF NAME CHANGE: 19990122
FORMER COMPANY:
FORMER CONFORMED NAME: CARDIOVASCULAR DYNAMICS INC
DATE OF NAME CHANGE: 19960506
4
1
wf-form4_154648099216564.xml
FORM 4
X0306
4
2018-12-30
0
0001013606
ENDOLOGIX INC /DE/
ELGX
0001740988
Thompson Matthew
2 MUSICK
IRVINE
CA
92618
0
1
0
0
Chief Medical Officer
Common Stock
2018-12-30
4
D
0
15000
0
D
53062
D
Common Stock
2018-12-30
4
A
0
470115
0
A
523177
D
Option to Purchase
0.7445
2018-12-30
4
A
0
225621
0.7445
A
2019-12-30
2028-12-30
Common Stock
225621.0
225621
D
Shares subject to this Form 4 were granted as part of a performance restricted stock unit granted May 31, 2017. All shares granted were forfeited as of March 13, 2018 due to the single performance milestone being deemed not achievable by the Company. This forfeiture was not previously reported to the Securities and Exchange Commission, as the number of shares was deemed immaterial by the issuer.
The time-based restricted stock unit award shall vest in three equal annual installments on December 30, 2019, December 30, 2020 and December 30, 2021 and shall settle in shares of common stock on each of those dates.
100% of the option award shall vest on December 30, 2019.
Matthew Thompson by Timothy N. Brady Attorney-in-Fact for Reporting Person
2019-01-02